Ebola virus disease: In vivo protection provided by the PAMP restricted TLR3 agonist rintatolimod and its mechanism of action

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2023
Source ID
10.1016/j.antiviral.2023.105554

Entities

People

  • Angela Corona
  • Annalaura Paulis
  • David Strayer
  • Enzo Tramontano
  • Gian Luca Daino
  • Simona Distinto
  • William M. Mitchell

Organizations

  • United States Army Medical Research Institute of Infectious Diseases